Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ritlecitinib Phase 2b Study in Active Non-segmental Vitiligo
NCT03715829Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 2018
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of ritlecitinib tosilate in nonsegmental vitiligo, sponsored by Pfizer. Started Nov 2018; status: completed.
02
Drugs
ritlecitinib tosilate
03
Conditions
nonsegmental vitiligo
Beyond the preview
Go deeper on NCT03715829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03715829.